Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
December 18, 2007
Patent Application Number
10295600
Date Filed
November 15, 2002
Patent Primary Examiner
Patent abstract
The present invention discloses protocols for HER cancers that are also endocrine dependent in a manner that provides dual action by using both HER antibodies and endocrine blockers/downregulators and insures function of S-Phase cytotoxics by administration of endocrines prior to administration of the S-Phase cytotoxic.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
